Want to see RXRX full AI Analyst Report?
Recursion Pharmaceuticals (RXRX) Q2 2024 Earnings Report
RXRX Q2 2024 EPS Results
- Actual EPS
- -$0.40
- Consensus EPS
- -$0.38
- Beat/Miss
- Missed by -$0.02
- One Year Ago EPS
- -$0.38
RXRX Q2 2024 Revenue Results
- Actual Revenue
- $14.42M
- Expected Revenue
- $11.96M
- Beat/Miss
- Beat by +$2.46M
- YoY Revenue Growth
- +30.86%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
RXRX Upcoming Earnings
Recursion Pharmaceuticals's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
RXRX Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
RXRX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.22- | -0.21 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.22-0.22 | -0.36 | 38.89% (+0.14) | |
| Aug 05, 2026 | 2026 (Q2) | -0.24-0.25 | -0.41 | 39.02% (+0.16) | |
| May 06, 2026 | 2026 (Q1) | -0.27-0.22 | -0.5 | 56.00% (+0.28) | |
| Feb 25, 2026 | 2025 (Q4) | -0.30-0.21 | -0.53 | 60.38% (+0.32) | |
| Nov 05, 2025 | 2025 (Q3) | -0.38-0.36 | -0.34 | -5.88% (-0.02) | |
| Aug 05, 2025 | 2025 (Q2) | -0.35-0.41 | -0.4 | -2.50% (-0.01) | |
| May 05, 2025 | 2025 (Q1) | -0.52-0.50 | -0.39 | -28.21% (-0.11) | |
| Feb 28, 2025 | 2024 (Q4) | -0.41-0.53 | -0.42 | -26.19% (-0.11) | |
| Nov 06, 2024 | 2024 (Q3) | -0.33-0.34 | -0.43 | 20.93% (+0.09) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
